ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,291.34
0.15%
Dow Jones
38,711.29
0.36%
US Dollar vs MXN
17.7659
-0.28%
Brent Oil
77.48
0.48%
Bitcoin
70,898.89
0.48%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Kindred Biosciences Inc (KIN)

  7. Kindred Biosciences Inc (KIN) Noticias

KIN

Kindred Biosciences (KIN)

Kindred Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:KIN
FechaHoraFuenteTítuloSímboloCompañía
14/02/202216:35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KINKindred Biosciences Inc
02/09/202105:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:KINKindred Biosciences Inc
30/08/202117:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KINKindred Biosciences Inc
30/08/202108:22Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KINKindred Biosciences Inc
30/08/202108:09Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:KINKindred Biosciences Inc
30/08/202108:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KINKindred Biosciences Inc
30/08/202108:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:KINKindred Biosciences Inc
27/08/202116:37Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:KINKindred Biosciences Inc
10/08/202105:01Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:KINKindred Biosciences Inc
05/08/202115:15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KINKindred Biosciences Inc
21/07/202108:11Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:KINKindred Biosciences Inc
09/07/202116:31Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:KINKindred Biosciences Inc
25/06/202115:33Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:KINKindred Biosciences Inc
25/06/202115:31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:KINKindred Biosciences Inc
16/06/202117:45PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kindred Biosciences, Inc.NASDAQ:KINKindred Biosciences Inc
16/06/202106:35Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:KINKindred Biosciences Inc
16/06/202105:30Business WireElanco Announces Agreement to Acquire Kindred BiosciencesNASDAQ:KINKindred Biosciences Inc
02/06/202107:31PR Newswire (US)Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Preventi...NASDAQ:KINKindred Biosciences Inc
25/05/202107:42PR Newswire (US)Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XINASDAQ:KINKindred Biosciences Inc
11/05/202115:03PR Newswire (US)Kindred Biosciences Announces First Quarter 2021 Financial ResultsNASDAQ:KINKindred Biosciences Inc
03/05/202107:42PR Newswire (US)Kindred Biosciences to Announce First Quarter 2021 Financial ResultsNASDAQ:KINKindred Biosciences Inc
29/04/202115:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:KINKindred Biosciences Inc
28/04/202107:32PR Newswire (US)Kindred Biosciences Announces Acceptance of Parvovirus Antibody Prophylaxis Study Data and Approval of Efficacy IndicationNASDAQ:KINKindred Biosciences Inc
20/04/202115:03PR Newswire (US)Kindred Biosciences Unveils Positive Results from its Long-Acting Interleukin-31 Antibody PK StudyNASDAQ:KINKindred Biosciences Inc
01/04/202116:14Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:KINKindred Biosciences Inc
16/03/202115:02PR Newswire (US)Kindred Biosciences Announces Fourth Quarter and Full Year 2020 Financial ResultsNASDAQ:KINKindred Biosciences Inc
08/03/202107:32PR Newswire (US)Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial ResultsNASDAQ:KINKindred Biosciences Inc
02/03/202107:31PR Newswire (US)Kindred Biosciences to Present at Barclays Global Healthcare Conference and H.C. Wainwright Global Life Sciences ConferenceNASDAQ:KINKindred Biosciences Inc
25/02/202107:01PR Newswire (US)Kindred Biosciences Announces Submission of Parvovirus Monoclonal Antibody Data for Prophylactic IndicationNASDAQ:KINKindred Biosciences Inc
16/02/202115:02PR Newswire (US)Kindred Biosciences to Present at the BofA Securities Animal Health Virtual SummitNASDAQ:KINKindred Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:KIN

Su Consulta Reciente

BIT
PA7581
Bnp Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados